Physician

Hector Raul Trevino, M.D.

According to 2025 Medicare claims, Hector Trevino, M.D. (NPI: 1346349354) practices family practice in the Eagle Pass, TX market, with the plurality of this provider's patient population coming from Maverick, TX. This provider's primary affiliated billing organization is HECTOR R. TREVINO, M.D., P.A. (NPI: 1740486208; TIN: 043669057) and primary practice location at 78852-7718. Trevino is affiliated with the Physician Leaders Direct Contracting Entity, LLC (ACO ID: D0171), participating under the REACH model.

Trevino's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 68 traditional Medicare patients, billed 567 HCPCS/CPT codes, and received $33,993 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 4,427 prescription claims across 295 beneficiaries totaling $631,310 in drug costs, led by Farxiga (Dapagliflozin Propanediol). 2023 DME data shows 43 claims. Open Payments data shows 14 records totaling $286. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $67,648 to $33,993. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $492,604 and ending at $631,310. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,376 and ending at $1,529.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	204	1,947	$67,648
2016	186	1,682	$53,948
2017	176	2,749	$65,943
2018	165	1,317	$60,161
2019	168	1,519	$59,693
2020	75	690	$27,674
2021	86	1,604	$45,772
2022	68	1,013	$50,410
2023	54	743	$46,825
2024	68	567	$33,993

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	293	6,223	$492,604
2016	259	5,815	$415,005
2017	240	5,149	$359,227
2018	351	5,850	$476,197
2019	281	3,950	$420,586
2020	217	2,683	$317,851
2021	500	4,786	$574,500
2022	400	4,707	$507,491
2023	270	4,134	$502,462
2024	295	4,427	$631,310

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	41	192	$4,607
2016	28	133	$5,477
2017	N/R	83	$3,807
2018	N/R	76	$666
2019	N/R	89	$5,460
2020	N/R	99	$6,413
2021	N/R	65	$1,621
2022	N/R	98	$5,420
2023	N/R	43	$750
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	28	58	$126
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	46	144	$81
99497	Advance care planning, first 30 minutes	30	30	$78
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	24	32	$55
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	29	70	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	91	3,790	$70,487
Mounjaro	Tirzepatide	63	1,820	$68,833
Januvia	Sitagliptin Phosphate	56	2,530	$47,487
Jardiance	Empagliflozin	31	2,340	$46,464
Ozempic	Semaglutide	42	1,344	$41,166

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$286	Lilly USA, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Hector Raul Trevino, M.D.?

Tedicare shows public-source Medicare data for Hector Raul Trevino, M.D. (NPI 1346349354), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Hector Raul Trevino, M.D. have ACO affiliation data?

Hector Raul Trevino, M.D. is shown with ACO affiliation data for Physician Leaders Direct Contracting Entity, LLC (REACH, ACO ID D0171).

What billing organization is linked to Hector Raul Trevino, M.D.?

Hector Raul Trevino, M.D. is linked to HECTOR R. TREVINO, M.D., P.A. (billing NPI 1740486208) in the available physician profile data.

Does Hector Raul Trevino, M.D. have Open Payments data?

Hector Raul Trevino, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.